Article
Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients.
European journal of cancer (Oxford, England : 1990) - 1 Jan 2013
Kim Kyung Im, Huh Ik-Soo, Kim In-Wha, Park Taesung, Ahn Kwang-Sung, Yoon Sung-Soo, Yoon Jeong-Hyun, Oh Jung Mi
Abstract excerpt
Cytarabine arabinoside (ara-C) is the key agent for treating acute myeloid leukaemia (AML). Here, we genotyped 139 single nucleotide polymorphisms (SNPs) within the ara-C transport and metabolic pathway using the Illumina Golden Gate Assay in 97 patients with previously non-treated de novo AML other than M3. DCK rs4694362 (CC genotype) was a significant poor prognostic factor for overall survival (OS) (hazard...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
